Back to top
more

Thermo Fisher Scientific (TMO)

(Delayed Data from NYSE)

$602.02 USD

602.02
1,316,881

+3.99 (0.67%)

Updated Aug 6, 2024 04:00 PM ET

After-Market: $601.70 -0.32 (-0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 39% (99 out of 251)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Thermo Fisher Scientific (TMO) Dips More Than Broader Markets: What You Should Know

Thermo Fisher Scientific (TMO) closed at $445.33 in the latest trading session, marking a -0.86% move from the prior day.

Moderna (MRNA) Files for Full Approval of COVID-19 Vaccine

Moderna (MRNA) seeks full approval for its COVID-19 vaccine, mRNA-1273, in adults with initiation of rolling submission of a BLA. The company also boosts manufacturing capacity for the vaccine.

LabCorp (LH) New Study Looks at COVID-19 Antibody Longevity

LabCorp (LH) claims this to be the largest known COVID-related study in terms of specimen volume.

Thermo Fisher's (TMO) New Alliance Boosts Electron Microscopy

This instrument by Thermo Fisher (TMO) is set to play a vital role in developing advanced solar cells, transport alloys, battery materials, low-energy electronics, catalysts and biodegradable polymers.

Thermo Fisher (TMO) to Boost Cell Therapies With UCSF Deal

Thermo Fisher's (TMO) collaboration with UCSF will enable end-to-end solution to accelerate cell therapy development and manufacturing with new facility.

The Zacks Analyst Blog Highlights: UnitedHealth, PayPal, NextEra Energy, Thermo Fisher Scientific and Anheuser-Busch InBev

The Zacks Analyst Blog Highlights: UnitedHealth, PayPal, NextEra Energy, Thermo Fisher Scientific and Anheuser-Busch InBev

Sheraz Mian headshot

Top Stock Reports for UnitedHealth, PayPal & NextEra

Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH), PayPal (PYPL), and NextEra (NEE).

Sweta Killa headshot

Healthcare ETFs on Radar As Q1 Earnings Unfold

Further price movement of the healthcare ETFs depend on earnings releases from some big names like Pfizer (PFE), Merck (MRK), Thermo Fisher (TMO), AbbVie (ABBV), and Gilead Sciences (GILD) that dominate returns.

Trina Mukherjee headshot

Medical Products' Apr 29 Earnings Roster: TMO, BAX & More

The Medical Product companies' first-quarter results are likely to reflect robust earnings and revenue growth on solid base business recovery.

Is a Surprise Coming for Thermo Fisher (TMO) This Earnings Season?

Thermo Fisher (TMO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

PerkinElmer (PKI) to Post Q1 Earnings: What's in the Cards?

PerkinElmer's (PKI) first-quarter results are likely to reflect strong performance at Diagnostics segment.

Thermo Fisher (TMO) to Report Q1 Earnings: WIll It Beat?

Fewer hospital visits on growing new cases might have once again impacted the level of routine diagnostics testing activity for Thermo Fisher (TMO) in Q1.

Baxter (BAX) to Report Q1 Earnings: What's in the Cards?

Baxter's (BAX) first-quarter results are likely to reflect growth in its Acute Therapies business.

DexCom (DXCM) to Report Q1 Earnings: What's in the Cards?

DexCom's (DXCM) first-quarter results are likely to reflect rising global awareness of its real-time CGM.

Thermo Fisher Scientific (TMO) Reports Next Week: Wall Street Expects Earnings Growth

Thermo Fisher (TMO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Stryker (SYK) to Report Q1 Earnings: What's in the Cards?

Stryker's (SYK) first-quarter results are likely to reflect strong segmental performances at Medsurg, Orthopaedic and Neurotechnology & Spine.

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Thermo Fisher (TMO) to Expand in Pharma Service With PPD Buyout

Thermo Fisher's (TMO) $17.4-billion acquisition deal will offer the company meaningful cost and revenue synergies.

Urmimala Biswas headshot

MedTech M&A Scaling New Heights in 2021 on Rising Investor Wealth

While smaller tuck-in acquisitions dominated the M&A space throughout 2020, 2021 is seeing a number of colossal deals.

Sweta Killa headshot

5 ETFs to Make the Most of Thermo Fisher Deal to Buy PPD

Thermo Fisher Scientific (TMO) has agreed to buy the healthcare testing company PPD Inc. (PPD) for $17.4 billion in cash.

Company News for Apr 16, 2021

Companies in the news are: BLK, PEP, DELL, TMO

What's in Store for Intuitive Surgical's (ISRG) Q1 Earnings?

Intuitive Surgical's (ISRG) first-quarter earnings are likely to reflect solid performance at Instruments & Accessories segment.

Thermo Fisher (TMO) Gets EUA for Amplitude/TaqPath COVID-19 Kit

Thermo Fisher's (TMO) Amplitude Solution is likely to allow clinical and public health laboratories to process up to 8,000 samples in a single day with the help of minimum workforce.

Thermo Fisher (TMO) Rides on End Markets as Pandemic Rages On

In diagnostics and healthcare, Thermo Fisher (TMO) is experiencing high demand for COVID-19 testing and manages to record 200% growth.

The Zacks Analyst Blog Highlights: Berkshire Hathaway, Thermo Fisher, T-Mobile, Medtronic and Square

The Zacks Analyst Blog Highlights: Berkshire Hathaway, Thermo Fisher, T-Mobile, Medtronic and Square